Form 4 holding
Chief Financial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 141,392
- Estimated value
- $500,641
- Report date
- 13 Feb 2024
- Price
- $3.54
- Ownership
- By Trust
John W. Smither - Chief Financial Officer at Arcutis Biotherapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- ARQT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by John W. Smither since 01 Aug 2025
Reported holdings for John W. Smither in Arcutis Biotherapeutics, Inc.
Form 4 holding
Chief Financial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 11,365
- Estimated value
- $40,241
- Report date
- 13 Feb 2024
- Price
- $3.54
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
Arcutis Biotherapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 13 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for John W. Smither in Arcutis Biotherapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.